Immunetrics’ predictive mathematical models address challenging questions. We train our models to multiple drug targets, therapeutic compounds, clinical trials, doses, and routes of administration, imparting a high level of confidence in our predictions.


Will a compound be efficacious for a specific indication?
What target engagement is required for the compound to be efficacious?
Will a developed compound be successful in another indication?

We design our models to be modular and easy to develop/maintain.

Our models can be expanded to incorporate new biology and to predict the efficacy of novel drugs. Customers take advantage of our extensive computational methods to lower overall drug development costs.